Continuity is the main challenge in treating major depressive disorder in psychiatric care

Journal of Clinical Psychiatry

Volumn 66, Issue 2, 2005, Pages 220-227

  Melartin, Tarja K ^a,b   Rytsälä, Heikki J ^a,b   Leskelä, Ulla S ^a,b   Lestelä Mielonen, Paula S ^a,b   Sokero, T Petteri ^a,b   Isometsä, Erkki T ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BUSPIRONE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ACUTE DISEASE; ADULT; ARTICLE; CLINICAL PRACTICE; DECISION MAKING; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; FEAR; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH CARE; MENTAL PATIENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; SIDE EFFECT; TREATMENT OUTCOME;

EID: 14644413445     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v66n0210     Document Type: Article

References (36)

1. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder [Revision]. Am J Psychiatry 2000;157(suppl 4):1-45
2. Bauer M, Whybrow PC, Angst J, et al. WFSBP Task Force on Treatment Guidelines for Unipolar Depressive Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, pt 1: acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 2002; 3:5-43
3. Anderson IM, Nutt DJ, Deakin JFW, on behalf of the British Association for Psychopharmacology. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. J Psychopharmacol 2000;14:3-20
4. Schulberg HC, Katon W, Simon GE, et al. Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. Arch Gen Psychiatry 1998;55:1121-1127
5. Isometsä E, Lindfors O, Pirkola S, et al. The National Finnish Current Care Guidelines for the Treatment of Depression: an overview. Psychiatria Fennica 2003;34:181-196
6. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA 1995;273:1026-1031
7. Lin EH, Katon WJ, Simon GE, et al. Low-intensity treatment of depression in primary care: is it problematic? Gen Hosp Psychiatry 2000;22:78-83
8. Demyttenaere K, Enzlin P, Dewe W, et al. Compliance with antidepressants in a primary care setting, 1: beyond lack of efficacy and adverse events. J Clin Psychiatry 2001;62(suppl 22):30-33
9. Von Korff M, Katon W, Unutzer J, et al. Improving depression care: barriers, solutions, and research needs. J Fam Pract 2001;50:E1
10. Melfi CA, Chawla AJ, Croghan TW, et al. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry 1998;55:1128-1132
11. Claxton AJ, Li Z, McKendrick J. Selective serotonin reuptake inhibitor treatment in the UK: risk of relapse or recurrence of depression. Br J Psychiatry 2000;177:163-168
12. Rytsälä HJ, Melartin TK, Leskelä US, et al. A record-based analysis of 803 patients treated for depression in psychiatric care. J Clin Psychiatry 2001;62:701-706
13. Simon GE, Von Korff M, Rutter CM, et al. Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians. Arch Gen Psychiatry 2001;58:395-401
14. Cuffel BJ, Azocar F, Tomlin M, et al. Remission, residual symptoms, and nonresponse in the usual treatment of major depression in managed clinical practice. J Clin Psychiatry 2003;64:397-402
15. Sirey JA, Myers BS, Bruce ML, et al. Predictors of antidepressant prescription and early use among depressed outpatients. Am J Psychiatry 1999;156:690-696
16. Kennedy N, Abbot R, Paykel ES. Remission and recurrence of depression in the maintenance era: long-term outcome of a Cambridge cohort. Psychol Med 2003;33:827-838
17. Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand 2002;105:164-172
18. Pampallona S, Bollini P, Tibaldi G, et al. Patient adherence in the treatment of depression. Br J Psychiatry 2002;180:104-109
19. Demyttenaere K. Risk factors and predictors of compliance in depression. Eur Neuropsychopharmacol 2003;13:S69-S75
20. Lin EHB, Von Korff M, Ludman EJ, et al. Enhancing adherence to prevent depression relapse in primary care. Gen Hosp Psychiatry 2003;25:303-310
21. Sirey JA, Bruce ML, Alexopoulos GS, et al. Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression. Am J Psychiatry 2001;158:479-481
22. Demyttenaere K, Haddad P. Compliance with antidepressant therapy and antidepressant discontinuation symptoms. Acta Psychiatr Scand 2000;101(suppl 403):50-56
23. Keller MB, Hirschfeld RMA, Demyttenaere K, et al. Optimizing outcomes in depression: focus on antidepressant compliance. Int Clin Psychopharmacol 2002;17:265-271
24. Melartin TK, Rytsälä HJ, Leskelä US, et al. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study. J Clin Psychiatry 2002; 63:126-134
25. Melartin TK, Rytsälä HJ, Leskelä US, et al. Severity and comorbidity predict episode duration and recurrence of DSM-IV major depressive disorder. J Clin Psychiatry 2004;65:810-819
26. Wing JK, Babor T, Brugha T, et al. SCAN: Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 1990;47:589-593
27. Spitzer RL, Williams JBW, Gibbon M, et al. Instruction Manual for the Structured Clinical Interview for DSM-III-R (SCID, 5/1/89 Revision). New York, NY: Biometrics Research; 1989
28. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
29. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol 1979;47:343-352
30. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571
31. Beck AT, Brown G, Epstein N, et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56: 893-897
32. Brugha TS, Sturt E, MacCarthy B, et al. The Interview Measure of Social Relationships: the description and evaluation of a survey instrument for assessing personal social resources. Soc Psychiatry 1987;22:123-128
33. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc B 1972;34:541-554
34. Statistical Package for the Social Sciences for Windows [computer program]. Release 11.0.1. Chicago, Ill: SPSS Inc; 1989-2001
35. Sturm R. Instrumental variable methods for effectiveness research. Int J Methods Psychiatr Res 1999;7:17-26
36. Paykel ES, Hart D, Priest R. Changes in public attitudes to depression during the Defeat Depression Campaign. Br J Psychiatry 1998;173: 519-522